Skip to content

Baxter International BAX Reportable Segment — Segment operating income

Other segment segments

Medical Products & Therapies
$186M-23.8%
Healthcare Systems & Technologies
$66M-29.0%
Pharmaceuticals
$46M-27.0%

Similar metrics at other companies

CSL
CSLReportable Segments — Operating Income
$274.78M-12.6%
Bentley Systems, Incorporated logo
BSYReportable Segment — Operating Income (Loss)
$126.26M+9.6%
Samsara logo
IOTReportable Segment — Operating Income (Loss)
$7.2M+122%
ImmunityBio, Inc. logo
IBRXReportable Segment — Operating Income (Loss)
-$69.79M-8.3%
BridgeBio Pharma logo
BBIOReportable Segment — Operating Income (Loss)
-$105.96M-1.5%
Williams-Sonoma logo
WSMReportable Segment — Operating Income (Loss)
$291.69M+0.3%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's reportable segment — segment operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's reportable segment — segment operating income?
Baxter International (BAX) reported reportable segment — segment operating income of $298M in Q1 2026.
How has Baxter International's reportable segment — segment operating income changed year-over-year?
Baxter International's reportable segment — segment operating income decreased by 25.5% year-over-year, from $400M to $298M.
What is the long-term trend for Baxter International's reportable segment — segment operating income?
Over 3 years (2022 to 2025), Baxter International's reportable segment — segment operating income has grown at a -16.9% compound annual growth rate (CAGR), from -$2.85B to $1.63B.
What does reportable segment — segment operating income mean?
The profit earned directly from the company's main business operations.
How do you interpret reportable segment — segment operating income?
An increase suggests improved operational efficiency or stronger product demand, while a decrease indicates margin pressure or operational challenges.
How does reportable segment — segment operating income compare across companies?
Commonly reported as Segment Operating Income or Segment EBIT by peers in the medical device and healthcare supply industry.